+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Cancer Therapeutics - Market Insight and R&D Pipeline Analysis

Brain Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Cancer Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Cancer Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gastrointestinal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gastrointestinal Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Ovarian Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Ovarian Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 450 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Esophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
FGFRpositive Gastroesophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

FGFRpositive Gastroesophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cervical Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Triple Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
TRK Fusion Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

TRK Fusion Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Checkpoint-Inhibitor Refractory Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Checkpoint-Inhibitor Refractory Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HER+ Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER+ Gastric Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
KRAS Mutant Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

KRAS Mutant Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Nonmelanoma Skin Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Nonmelanoma Skin Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
T-Cell Blood Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

T-Cell Blood Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator